Strategic Partnerships Tidepool has a track record of collaborating with di abetes-focused organizations and device makers (e.g., Medtronic, Ōura, HealthPartners) to advance interoperable automated insulin delivery and data reporting. This indicates strong sales potential for expanding partnerships with insulin pump manufacturers, CGM companies, and diabetes research institutions.

Open Source Platform With a nonprofit open source model and a platform that includes Tidepool Web, Uploader, and Mobile, there is opportunity to offer enterprise support, premium data analysis tools, or professional services around data integration, interoperability, and custom reporting for clinics and researchers.

Regulatory Ambition Tidepool Loop aims to be FDA-regulated and app store available, signaling a readiness to engage with health tech vendors seeking compliant, interoperable automated insulin delivery solutions. Potential customers include clinics, partners, and payers prioritizing approved, interoperable ecosystems.

Clinical Impact & Events Public activities like ADA 2026 demonstrations and presentations on real-world clinical data and women's health initiatives highlight active visibility in clinical communities, creating opportunities for sponsorship, joint webinars, and beta programs with healthcare providers and academic centers.

Funding & Scale Revenue is in the tens of millions, suggesting a sustainable financial base to support enterprise engagements, professional services, and long-term collaboration initiatives with larger diabetes tech companies and healthcare systems seeking standardized data workflows.